Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138341000087117 | VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 96651000087111 | VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Live attenuated Human alphaherpesvirus 3 Oka strain antigen | false | Inferred relationship | Some | 1 | |
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Var varicella unspecified | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Varicella-zoster live attenuated vaccine | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only live attenuated Human alphaherpesvirus 3 Oka strain antigen (medicinal product) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | est un(e) (attribut) | Varicella virus vaccine (product) | false | Inferred relationship | Some | ||
| VARILRIX 3300000 plaque forming units per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) | a pour principe actif (attribut) | Varicella virus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR